Miltenyi Biotec GmbH:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Miltenyi Biotec GmbH - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C10814
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:29
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:ドイツ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Miltenyi Biotec GmbH (Miltenyi) is a biotechnology company that offers biomedical research and cellular therapy products for cell isolation, flow cytometry, sample preparation and cell culture. The company offers sample preparation, cell separation, flow cytometry, cell culture and stimulation, cell therapy, cell manufacturing, therapeutic apheresis, molecular and imaging products. Its cell separation products comprise cell separation reagents, cell separation instruments, columns, separators, and buffers and solutions. Miltenyi also offers instrument services, technical support, ordering and delivery and customized application services. The company operates in Germany, the US, the UK, France, Italy, Singapore, Japan, South Korea and others. Miltenyi is headquartered in Bergisch Gladbach, Germany.

Miltenyi Biotec GmbH – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Miltenyi Biotec GmbH, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Miltenyi Biotec GmbH, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Miltenyi Biotec GmbH, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Miltenyi Biotec GmbH, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Miltenyi Biotec GmbH, Medical Devices Deals, 2012 to YTD 2018 9
Miltenyi Biotec GmbH, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Miltenyi Biotec GmbH, Pharmaceuticals & Healthcare, Deal Details 11
Asset Purchase 11
Miltenyi Biotec Acquires Gene Therapy Assets from Lentigen 11
Venture Financing 12
Owl Biomedical Raises US$3 Million In Series A Financing 12
Partnerships 13
GlaxoSmithKline Enters into Agreement with Miltenyi Biotec 13
Cesca Therapeutics Enters into Distribution Agreement with Miltenyi Biotec 14
Applied Microarrays Enters Into Co-Development Agreement With Sensovation For FlexiPlex Array System 15
Licensing Agreements 16
Miltenyi Biotec Enters into Licensing Agreement with Genethon 16
Living Pharma Enters into Licensing Agreement with University of Maryland, Baltimore 17
Accellta Enters into Licensing Agreement with Miltenyi Biotec 18
Nanolek To Enter Into Licensing Agreement With Lentigen For Flu Vaccine 19
Asset Transactions 20
Miltenyi Biotec Acquires Gene Therapy Assets from Lentigen 20
Acquisition 21
Miltenyi Biotec Acquires LaVision BioTec 21
Lentigen Technology Acquires Living Pharma 22
Miltenyi Biotec Acquires Sensovation 23
Miltenyi Biotec Acquires Owl Biomedical, Disposable Cell Sorting Technology Provider 24
Miltenyi Biotec GmbH – Key Competitors 25
Miltenyi Biotec GmbH – Key Employees 26
Miltenyi Biotec GmbH – Locations And Subsidiaries 27
Head Office 27
Other Locations & Subsidiaries 27
Appendix 29
Methodology 29
About GlobalData 29
Contact Us 29
Disclaimer 29

List of Tables
Miltenyi Biotec GmbH, Pharmaceuticals & Healthcare, Key Facts 2
Miltenyi Biotec GmbH, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Miltenyi Biotec GmbH, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Miltenyi Biotec GmbH, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Miltenyi Biotec GmbH, Deals By Therapy Area, 2012 to YTD 2018 8
Miltenyi Biotec GmbH, Medical Devices Deals, 2012 to YTD 2018 9
Miltenyi Biotec GmbH, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Miltenyi Biotec Acquires Gene Therapy Assets from Lentigen 11
Owl Biomedical Raises US$3 Million In Series A Financing 12
GlaxoSmithKline Enters into Agreement with Miltenyi Biotec 13
Cesca Therapeutics Enters into Distribution Agreement with Miltenyi Biotec 14
Applied Microarrays Enters Into Co-Development Agreement With Sensovation For FlexiPlex Array System 15
Miltenyi Biotec Enters into Licensing Agreement with Genethon 16
Living Pharma Enters into Licensing Agreement with University of Maryland, Baltimore 17
Accellta Enters into Licensing Agreement with Miltenyi Biotec 18
Nanolek To Enter Into Licensing Agreement With Lentigen For Flu Vaccine 19
Miltenyi Biotec Acquires Gene Therapy Assets from Lentigen 20
Miltenyi Biotec Acquires LaVision BioTec 21
Lentigen Technology Acquires Living Pharma 22
Miltenyi Biotec Acquires Sensovation 23
Miltenyi Biotec Acquires Owl Biomedical, Disposable Cell Sorting Technology Provider 24
Miltenyi Biotec GmbH, Key Competitors 25
Miltenyi Biotec GmbH, Key Employees 26
Miltenyi Biotec GmbH, Other Locations 27
Miltenyi Biotec GmbH, Subsidiaries 27

List of Figures
Miltenyi Biotec GmbH, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Miltenyi Biotec GmbH, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Miltenyi Biotec GmbH, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Miltenyi Biotec GmbH, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Miltenyi Biotec GmbH, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Miltenyi Biotec GmbH, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Miltenyi Biotec GmbH, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Miltenyi Biotec GmbH, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Miltenyi Biotec GmbH, Medical Devices Deals, 2012 to YTD 2018 9

★海外企業調査レポート[Miltenyi Biotec GmbH:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Silence Therapeutics Plc (SLN):企業の財務・戦略的SWOT分析
    Summary Silence Therapeutics plc (Silence Therapeutics), formerly SR Pharma plc is a developer of therapeutics that channels gene silencing to cure disease. The company develops pipeline products such as Atu027 and Atu111. Its Atu027 is developed for the treatment of pancreatic, head and neck cancer …
  • SURUGA bank Ltd:企業の戦略・SWOT・財務情報
    SURUGA bank Ltd - Strategy, SWOT and Corporate Finance Report Summary SURUGA bank Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • LEO Pharma AS-医療機器分野:企業M&A・提携分析
    Summary LEO Pharma A/S (LEO Pharma) is a research-based pharmaceutical company. It undertakes the discovery, development, manufacture and commercialization of pharmaceuticals in the therapeutic areas dermatology and thrombosis. The company focuses on the treatment of diseases such as psoriasis, ecze …
  • Mereo Biopharma Group Plc (MPH):製薬・医療:M&Aディール及び事業提携情報
    Summary Mereo Biopharma Group Plc (Mereo), formerly Mereo Biopharma Group Ltd is a specialty bio-pharmaceutical company which develops novel medicines for the treatment of rare and specialty diseases. The company’s pipeline products include BPS-804, which is used for the treatment of brittle bone sy …
  • Charles River Laboratories International, Inc.:戦略・SWOT・企業財務分析
    Charles River Laboratories International, Inc. - Strategy, SWOT and Corporate Finance Report Summary Charles River Laboratories International, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, ope …
  • ReproCELL Inc (4978):企業の財務・戦略的SWOT分析
    Summary ReproCELL Inc (ReproCELL) is a biotechnology company that develops and commercializes stem cell technologies. The company offers products in divisions such as research reagents, cultivation materials, and cell and biorepository. Its research reagent products include hES iPSC culture reagents …
  • SK Telecom Co., Ltd.:企業の戦略・SWOT・財務分析
    SK Telecom Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary SK Telecom Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • IPCA Laboratories Ltd (IPCALAB):企業の財務・戦略的SWOT分析
    Summary IPCA Laboratories Ltd (IPCA) is a manufacturer and supplier of active pharmaceutical ingredients (API’s), generics and branded formulations. It is one of India's largest formulation exporters and is specialized in anti-malarial and anti-bacterials therapeutic segments. The company offers API …
  • New Jersey Resources Corp (NJR):企業の財務・戦略的SWOT分析
    New Jersey Resources Corp (NJR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weak …
  • Copperbelt Energy Corporation Plc (CEC):企業の財務・戦略的SWOT分析
    Copperbelt Energy Corporation Plc (CEC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths …
  • Quorum Health Corp (QHC):企業の財務・戦略的SWOT分析
    Summary Quorum Health Corp (QHC) is a healthcare service provider that offers outpatient services. The center owns and leases hospitals and outpatient centers across the US. Its hospitals provides general hospital health-care services including general acute care, emergency room, general and special …
  • Caspian Sunrise Plc (CASP):石油・ガス:M&Aディール及び事業提携情報
    Summary Caspian Sunrise Plc (Caspian), formerly Roxi Petroleum plc, is an oil and gas exploration and development company. The company acquires, explores and develops crude oil. It holds interests in the exploration and production of BNG contract area in the Pre-Caspian basin and the Mangyshlak basi …
  • American Water Works Co Inc (AWK):企業の財務・戦略的SWOT分析
    Summary American Water Works Co Inc (AWW) is a utility company that offers fire protection and sanitation services. The company's services include water and wastewater services, military services, municipal and industrial contract, residual and home owner services. Its home owner services include wa …
  • Shin-Etsu Chemical Co Ltd (4063):企業の財務・戦略的SWOT分析
    Shin-Etsu Chemical Co Ltd (4063) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • UTC Engenharia SA:企業の戦略的SWOT分析
    UTC Engenharia SA - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and serv …
  • Tourism Holdings Limited
    Tourism Holdings Limited - Strategy, SWOT and Corporate Finance Report Summary Tourism Holdings Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Southwestern Electric Power Co:企業の発電所・SWOT分析2018
    Southwestern Electric Power Co - Power Plants and SWOT Analysis, 2018 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on ke …
  • Acer Therapeutics Inc (ACER):医療機器:M&Aディール及び事業提携情報
    Summary Acer Therapeutics Inc (Acer), formerly Opexa Therapeutics Inc is a pharmaceutical company that offers acquisition, development and commercialization of therapies for patients with serious rare diseases. The company offers treatment of autoimmune disorders, rheumatoid arthritis, diabetes and …
  • Danville Materials Inc:医療機器:M&Aディール及び事業提携情報
    Summary Danville Materials Inc (Danville), a subsidiary of Inverness Graham Investments is a medical device company that manufactures dental equipment. The company provides posts, air abrasion, tin plating, adhesives, sand blasting, composites, air polishing, dust cabinets, microetcher, and IPR. It …
  • EBOS Group Ltd (EBO):製薬・医療:M&Aディール及び事業提携情報
    Summary EBOS Group Ltd (EBOS) is a healthcare products supplier that markets, sells and distributes healthcare, medical and pharmaceutical products. It also markets and distributes animal care products and offers distribution, warehousing and logistics support to pharmaceutical manufacturers and med …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆